Intracellular bacteria as targets and carriers for vaccination

Biological Chemistry

Volumn 382, Issue 4, 2001, Pages 521-532

  Mollenkopf, Hans ^a   Dietrich, Guido ^b   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

DNA vaccines; Heterologous antigen expression; Mycobacterium tuberculosis; Recombinant vaccine carrier strains; Vaccine delivery

Indexed keywords

ANTIGEN; DNA; DNA VACCINE; DRUG CARRIER; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NUCLEIC ACID; RECOMBINANT ANTIGEN; SALMONELLOSIS VACCINE; TUMOR ANTIGEN; TYPHOID VACCINE;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; BACTERIAL VIRULENCE; CAUSE OF DEATH; CELL SECRETION; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; INFECTION; LISTERIA MONOCYTOGENES; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR PHAGOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENICITY; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE; TUBERCULOSIS; TYPHOID FEVER; VACCINATION;

ANIMALS; ANTIGENS, HETEROPHILE; BACTERIAL VACCINES; CYTOPLASM; DRUG CARRIERS; GENETIC VECTORS; HUMANS; LISTERIA MONOCYTOGENES; MYCOBACTERIUM TUBERCULOSIS; PHAGOSOMES; SALMONELLA; SALMONELLA VACCINES; TUBERCULOSIS; VACCINATION; VACCINES, DNA;

ANIMALIA; BACTERIA (MICROORGANISMS); LISTERIA MONOCYTOGENES; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SALMONELLA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0034998394     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.066     Document Type: Review

References (161)

1. Abdelhak, S., Louzir, H., Timm, J., Blel, L., Benlasfar, Z., Lagranderie, M., Gheorghiu, M., Dellagi, K., and Gicquel, B. (1995). Recombinant BCG expressing the leishmania surface antigen Gp63 induces protective immunity against Leishmania major infection in BALB/c mice. Microbiology 141, 1585-1592.
2. Abomoelak, B., Huygen, K., Kremer, L., Turneer, M., and Locht, C. (1999). Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guerin producing a pertussis toxin-tetanus toxin hybrid protein. Infect. Immun. 67, 5100-5105.
3. + T cells. J. Exp. Med. 191, 551-560.
4. Alvarez-Dominguez, C., Roberts, R., and Stahl, P. D. (1997). Internalized Listeria monocytogenes modulates intracellular trafficking and delays maturation of the phagosome. J. Cell. Sci. 110, 731-743.
5. Andersen, P. (1994). Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect. Immun. 62, 2536-2544.
6. Anderson, R. J., Pasetti, M. F., Sztein, M. B., Levine, M. M., and Noriega, F. R. (2000). DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin. Vaccine 18, 2193-2202.
7. Andrews, N. W., and Portnoy, D. A. (1994). Cytolysins from intracellular pathogens. Trends Microbiol. 2, 261-263.
8. Bachmann, M. F., and Kopf, M. (1999). The role of B cells in acute and chronic infections. Curr. Opin. Immunol. 11, 332-339.
9. Baldwin, S. L., D'Souza, C., Roberts, A. D., Kelly, B. P., Frank, A. A., Lui, M. A., Ulmer, J. B., Huygen, K., McMurray, D. M., and Orme, I. M. (1998). Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66, 2951-2959.
10. Barry, M. A., Lai, W. C., and Johnston, S. A. (1995). Protection against mycoplasma infection using expression-library immunization. Nature 377, 632-635.
11. Behr, M. A., and Small, P. M. (1999). A historical and molecular phylogeny of BCG strains. Vaccine 17, 915-922.
12. Behr, M. A., Wilson, M. A., Gill, W. P., Salamon, H., Schoolnik, G. K., Rane, S., and Small, P. M. (1999). Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284, 1520-1523.
13. Berche, P., Gaillard, J. L., and Sansonetti, P. J. (1987). Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J. Immunol. 138, 2266-2271.
14. Berthet, F. X., Lagranderie, M., Gounon, P., Laurent-Winter, C., Ensergueix, D., Chavarot, P., Thouron, F., Maranghi, E., Pelicic, V. et al. (1998). Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 282, 759-762.
15. Beutler, B. (2000). Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 12, 20-26.
16. Bloom, B. R., and Fine, P. E. (1994). The BCG experience: implications for future vaccines against tuberculosis. In: Tuberculosis: Pathogenesis, Protection and Control, B. R. Bloom, ed. (Washington, D.C., USA: American Society for Microbiology), pp. 531-557
17. Boehm, U., Klamp, T., Groot, M., and Howard, J. C. (1997). Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15, 749-795.
18. Brandt, L., Elhay, M., Rosenkrands, I., Lindblad, E. B., and Andersen, P. (2000). ESAT 6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun. 68, 791-795.
19. Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R. B., Belisle, J. T., Bleharski, J. R., Maitland, M., Norgard, M. V., Plevy, S. E., Smale, S. T. et al. (1999). Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285, 732-736.
20. Brightbill, H. D., and Modlin, R. L. (2000). Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology 101, 1-10.
21. Brosch, R., Gordon, S. V., Billault, A., Gamier, T., Eiglmeier, K., Soravito, C., Barrell, B. G., and Cole, S. T. (1998). Use of a Mycobacterium tuberculosis H37Rv bacterial artificial chromosome library for genome mapping, sequencing, and comparative genomics. Infect. Immun. 66, 2221-2229.
22. Brosch, R., Philipp, W. J., Stavropoulos, E., Colston, M. J., Cole, S. T., and Gordon, S. V. (1999). Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect. Immun. 67, 5768-5774.
23. Brosch, R., Gordon, S. V., Pym, A., Eiglmeier, K., Garnier, T., and Cole, S. T. (2000). Comparative genomics of the mycobacteria. Int. J. Med. Microbiol. 290, 143-152.
24. Brunham, R. C., and Zhang, D. (1999). Transgene as vaccine for chlamydia. Am. Heart J. 138, S519-522.
25. Buchmeier, N., Blanc-Potard, A., Ehrt, S., Piddington, D., Riley, L., and Groisman, E. A. (2000). A parallel intraphagosomal survival strategy shared by mycobacterium tuberculosis and Salmonella enterica. Mol. Microbiol. 35, 1375-1382.
26. Camacho, L. R., Ensergueix, D., Perez, E., Gicquel, B., and Guilhot, C. (1999). Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34, 257-267.
27. Cardenas, L., and Clements, J. D. (1992). Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin. Microbiol. Rev. 5, 328-342.
28. Casadevall, A. (1998). Antibody-mediated protection against intracellular pathogens. Trends Microbiol. 6, 102-107.
29. Catic, A., Dietrich, G., Gentschev, I., Goebel, W., Kaufmann, S. H., and Hess, J. (1999). Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages. Microbes. Infect. 1, 113-121.
30. Chattergoon, M. A., Robinson, T. M., Boyer, J. D., and Weiner, D. B. (1998). Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J. Immunol. 160, 5707-5718.
31. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., 3rd et al. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
32. Condon, C., Watkins, S. C., Celluzzi, C. M., Thompson, K., and Falo, L. D., Jr. (1996). DNA-based immunization by in vivo transfection of dendritic cells. Nature Med. 2, 1122-1128.
33. Connell, N. D., Medina-Acosta, E., McMaster, W. R., Bloom, B. R., and Russell, D. G. (1993). Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guerin expressing the Leishmania surface proteinase gp63. Proc. Natl. Acad. Sci. USA 90, 11473-11477.
34. Conradt, P., Hess, J., and Kaufmann, S. H. (1999). Cytolytic T cell responses to human dendritic cells and macrophages infected with Mycobacterium bovis BCG and recombinant BCG secreting listeriolysin. Microbes Infect. 1, 753-764.
35. Cornell, K. A., Bouwer, H. G., Hinrichs, D. J., and Barry, R. A. (1999). Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O. J. Immunol. 163, 322-329.
36. Corr, M., Lee, D. J., Carson, D. A., and Tighe, H. (1996). Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555-1560.
37. Cossart, P., and Lecuit, M. (1998). Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. EMBO J. 17, 3797-3806.
38. Courvalin, P., Goussard, S., and Grillot-Courvalin, C. (1995). Gene transfer from bacteria to mammalian cells. C. R. Acad. Sci. III 378, 1207-1212.
39. Darji, A., Guzman, C. A., Gerstel, B., Wachholz, P., Timmis, K. N., Wehland, J., Chakraborty, T., and Weiss, S. (1997). Oral somatic transgene vaccination using attenuated S. typhimurium. Cell 91, 755-775.
40. Deck, R. R., DeWitt, C. M., Donnelly, J. J., Liu, M. A., and Ulmer, J. B. (1997). Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine 15, 71-78.
41. Dietrich, G., Bubert, A., Gentschev, I., Sokolovic, Z., Simm, A., Catic, A., Kaufmann, S. H., Hess, J., Szalay, A. A., and Goebel, W. (1998). Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nature Biotechnol. 16, 181-185.
42. Doe, B., Selby, M., Barnett, S., Baenziger, J., and Walker, C. M. (1996). Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578-8583.
43. Donnelly, J. J., Ulmer, J. B., Shiver, J. W., and Liu, M. A. (1997). DNA vaccines. Annu. Rev. Immunol. 15, 617-648.
44. + T cells in mice vaccinated with DNA encoding Ag85A. Eur. J. Immunol. 30, 2455-2459.
45. Duda, R. B., Yang, H., Dooley, D. D., and Abu-Jawdeh, G. (1995). Recombinant BCG therapy suppresses melanoma tumor growth. Ann. Surg. Oncol. 2, 542-549.
46. Ernst, W. A., Thoma-Uszynski, S., Teitelbaum, R., Ko, C., Manson, D. A., Clayberger, C., Krensky, A. M., Leippe, M., Bloom, B. R., Ganz, T., and Modlin, R. L. (2000). Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 165, 7102-7108.
47. Feltquate, D. M., Heaney, S., Webster, R. G., and Robinson, H. L. (1997). Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158, 2278-2284.
48. Fennelly, G. J., Khan, S. A., Abadi, M. A., Wild, T. F., and Bloom, B. R. (1999). Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector. J. Immunol. 162, 1603-1610.
49. Fensterle, J., Grode, L., Hess, J., and Kaufmann, S. H. (1999). Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun. J. Immunol. 163, 4510-4518.
50. Fine, P. E. (1995). Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346, 1339-1345.
51. Fujimoto, T., O'Donnell, M. A., Szilvasi, A., Yang, H., and Duda, R. B. (1996). Bacillus Calmette-Guerin plus interleukin-2 and/or granulocyte/macrophage-colony-stimulating factor enhances immunocompetent cell production of interferon-gamma, which inhibits B16F10 melanoma cell growth in vitro. Cancer Immunol. Immunother. 42, 280-284.
52. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1995). DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17, 79-83.
53. Gabaglia, C. R., Pedersen, B., Hitt, M., Burdin, N., Sercarz, E. E., Graham, F. L., Gauldie, J., and Braciak, T. A. (1999). A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice. J. Immunol. 162, 753-760.
54. Gentschev, I., Sokolovic, Z., Mollenkopf, H. J., Hess, J., Kaufmann, S. H., Kuhn, M., Krohne, G. F., and Goebel, W. (1995). Salmonella strain secreting active listeriolysin changes its intracellular localization. Infect. Immun. 63, 4202-4205.
55. Gentschev, I., Mollenkopf, H., Sokolovic, Z., Hess, J., Kaufmann, S. H., and Goebel, W. (1996). Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway. Gene 179, 133-140.
56. Geoffroy, C., Gaillard, J. L., Alouf, J. E., and Berche, P. (1987). Purification, characterization, and toxicity of the sulfhydryl-activated hemolysin listeriolysin O from Listeria monocytogenes. Infect. Immun. 55, 1641-1646.
57. Goebel, W., and Kreft, J. (1997). Cytolysins and the intracellular life of bacteria. Trends Microbiol. 5, 86-88.
58. Graham, J. E., and Clark-Curtiss, J. E. (1999). Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc. Natl. Acad. Sci. USA 96, 11554-11559.
59. Grillot-Courvalin, C., Goussard, S., Huetz, F., Ojcius, D. M., and Courvalin, P. (1998). Functional gene transfer from intracellular bacteria to mammalian cells. Nature Biotechnol. 16, 862-866.
60. Guleria, I., Teitelbaum, R., McAdam, R. A., Kalpana, G., Jacobs, W. R., Jr., and Bloom, B. R. (1996). Auxotrophic vaccines for tuberculosis. Nature Med. 2, 334-337.
61. Hanke, T., and McMichael, A. (1999). Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS. Immunol. Lett. 66, 177-181.
62. Hayward, C. M., O'Gaora, P., Young, D. B., Griffin, G. E., Thole, J., Hirst, T. R., Castello-Branco, L. R., and Lewis, D. J. (1999). Construction and murine immunogenicity of recombinant Bacille Calmette Guerin vaccines expressing the B subunit of Escherichia coli heat labile enterotoxin. Vaccine 17, 1272-1281.
63. Hedley, M. L., Curley, J., and Urban, R. (1998). Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses. Nature Med. 4, 365-368.
64. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
65. Herrington, D. A., Van de Verg, L., Formal, S. B., Hale, T. L., Tall, B. D., Cryz, S. J., Tramont, E. C., and Levine, M. M. (1990). Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine 8, 353-357.
66. Hess, J., Gentschev, I., Miko, D., Welzel, M., Ladel, C., Goebel, W., and Kaufmann, S. H. (1996). Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA 93, 1458-1463.
67. Hess, J., Miko, D., Gentschev, I., Dietrich, G., Goebel, W., Mollenkopf, H. J., Ladel, C., and Kaufmann, S. H. (1997). Modulation of antigen display by attenuated Salmonella typhimurium strains and its impact on protective immunity against listeriosis. Behring Inst. Mitt., 160-171.
68. Hess, J., Miko, D., Catic, A., Lehmensiek, V., Russell, D. G., and Kaufmann, S. H. (1998). Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc. Natl. Acad. Sci. USA 95, 5299-5304.
69. Hess, J., Schaible, U., Raupach, B., and Kaufmann, S. H. (2000a). Exploiting the immune system: toward new vaccines against intracellular bacteria. Adv. Immunol. 75, 1-88.
70. Hess, J., Grode, L., Hellwig, J., Conradt, P., Gentschev, I., Goebel, W., Ladel, C., and Kaufmann, S. H. (2000b). Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG. FEMS Immunol. Med. Microbiol. 27, 283-289.
71. Hess, J., Grode, L., Gentschev, I., Fensterle, J., Dietrich, G., Goebel, W., and Kaufmann, S.H. (2000c). Secretion of different listeriolysin cognates by recombinant attenuated Salmonella typhimurium: superior efficacy of haemolytic over non-haemolytic constructs after oral vaccination. Microbes Infect. 2, 1799-1806.
72. Himmelrich, H., Lo-Man, R., Winter, N., Guermonprez, P., Sedlik, C., Rojas, M., Monnaie, D., Gheorghiu, M., Lagranderie, M., Hofnung, M., et al. (2000). Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: maIE. Vaccine 18, 2636-2647.
73. Hohlfeld, R., and Engel, A. G. (1994). The immunobiology of muscle. Immunol. Today 15, 269-274.
74. Hoiseth, S. K., and Stocker, B. A. (1981). Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238-239.
75. Hondalus, M. K., Bardarov, S., Russell, R., Chan, J., Jacobs, W. R., Jr., and Bloom, B. R. (2000). Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68, 2888-2898.
76. Hormaeche, C., and Khan, C. M. (1996). Recombinant bacteria as vaccine carriers of heterologous antigens. In: Concepts in vaccine development, S.H. Kaufmann, ed. (Berlin, Germany: Walter de Gruyter), pp. 327-349
77. Hubbard, R. D., Flory, C. M., and Collins, F. M. (1992). Immunization of mice with mycobacterial culture filtrate proteins. Clin. Exp. Immunol. 87, 94-98.
78. Huygen, K. (1998). DNA vaccines: application to tuberculosis. Int. J. Tuberc. Lung Dis. 2, 971-978.
79. Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Deck, R. R., DeWitt, C. M., Orme, I. M., Baldwin, S., D'-Souza, C. et al. (1996). Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med. 2, 893-898.
80. Ikonomidis, G., Paterson, Y., Kos, F. J., and Portnoy, D. A. (1994). Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes. J. Exp. Med. 180, 2209-2218.
81. Iwasaki, A., Stiernholm, B. J., Chan, A. K., Berinstein, N. L., and Barber, B. H. (1997). Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591-4601.
82. Jabbar, I. A., Fernando, G. J., Saunders, N., Aldovini, A., Young, R., Malcolm, K., and Frazer, I. H. (2000). Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins. Vaccine 18, 2444-2453.
83. Jackson, M., Phalen, S. W., Lagranderie, M., Ensergueix, D., Chavarot, P., Marchal, G., McMurray, D. N., Gicquel, B., and Guilhot, C. (1999). Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect. Immun. 67, 2867-2873.
84. Johnston, S. A., and Barry, M. A. (1997). Genetic to genomic vaccination. Vaccine 15, 808-809.
85. Jondal, M., Schirmbeck, R., and Reimann, J. (1996). MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302.
86. Jungblut, P. R., Schaible, U. E., Mollenkopf, H.-J., Zimny-Arndt, U., Raupach, B., Mattow, J., Halada, P., Lamer, S., Hagens, K., and Kaufmann, S. H. (1999). Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol. Microbiol. 33, 1103-1117.
87. Kamath, A. T., Hanke, T., Briscoe, H., and Britton, W. J. (1999). Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T cell immunity, but not protective efficacy against Mycobacterium tuberculosis. Immunology 96, 511-516.
88. Kaufmann, S. H. (1998). Immunity to intracellular bacteria. In: Fundamental Immunology, W. Paul, ed. (New York, USA: Raven Press Ltd.), pp. 1335-1371.
89. Kaufmann, S. H. (2000). Is the development of a new tuberculosis vaccine possible? Nature Med. 6, 955-960.
90. Kaufmann, S. H., Fensterle, J., and Hess, J. (1999). The need for a novel generation of vaccines. Immunobiology 201, 272-282.
91. Kim, J. J., Ayyavoo, V., Bagarazzi, M. L., Chattergoon, M. A., Dang, K., Wang, B., Boyer, J. D., and Weiner, D. B. (1997). In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158, 816-826.
92. Kim, J. J., Yang, J. S., Dentchev, T., Dang, K., and Weiner, D. B. (2000). Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines. J. Interferon Cytokine Res. 20, 487-498.
93. Kuklin, N., Daheshia, M., Karem, K., Manickan, E., and Rouse, B. T. (1997). Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71, 3138-3145.
94. Lagranderie, M., Balazuc, A. M., Gicquel, B., and Gheorghiu, M. (1997). Oral immunization with recombinant Mycobacterium bovis BCG simian immunodeficiency virus nef induces local and systemic cytotoxic T lymphocyte responses in mice. J. Virol. 71, 2303-2309.
95. Langermann, S., Palaszynski, S., Sadziene, A., Stover, C. K., and Koenig, S. (1994). Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi. Nature 372, 552-555.
96. Leung, N. J., Aldovini, A., Young, R., Jarvis, M. A., Smith, J. M., Meyer, D., Anderson, D. E., Carlos, M. P., Gardner, M. B., and Torres, J. V. (2000). The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins. Virology 268, 94-103.
97. Lowrie, D. B., Silva, C. L., and Tascon, R. E. (1997). Genetic vaccination against tuberculosis. Springer Sem. Immunopathol. 19, 161-173.
98. Lowrie, D. B., Tascon, R. E., Bonato, V. L., Lima, V. M., Faccioli, L. H., Stavropoulos, E., Colston, M. J., Hewinson, R. G., Moelling, K., and Silva, C. L. (1999). Therapy of tuberculosis in mice by DNA vaccination. Nature 400, 269-271.
99. Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., and Stover, C. K. (1996). Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178, 1274-1282.
100. Mathiesen, I. (1999). Electropermeabilization of skeletal muscle enhances gene transfer in vivo. Gene Ther. 6, 508-514.
101. Matsumoto, S., Yukitake, H., Kanbara, H., and Yamada, T. (1998). Recombinant Mycobacterium bovis bacillus Calmette-Guerin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies. J. Exp. Med. 188, 845-854.
102. Mazzaccaro, R. J., Gedde, M., Jensen, E. R., van Santen, H. M., Ploegh, H. L., Rock, K. L., and Bloom, B. R. (1996). Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 93, 11786-11791.
103. McCluskie, M. J., Chu, Y., Xia, J. L., Jessee, J., Gebyehu, G., and Davis, H. L. (1998). Direct gene transfer to the respiratory tract of mice with pure plasmid and lipid-formulated DNA. Antisense Nucleic Acid Drug Dev. 8, 401-414.
104. Mollenkopf, H.-J., Gentschev, I., and Goebel, W. (1996). Conversion of bacterial gene products to secretion-competent fusion proteins. Biotechniques 21, 854, 856-860.
105. Mollenkopf, H.-J., Groine-Triebkom, D., Andersen, P., Hess, J. and Kaufmann, S. H. (2001). Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA. Vaccine, in press.
106. Murray, J. F. (1997). Tuberculosis and HIV infection: global perspectives. Respirology 2, 209-213.
107. Murray, C. J., and Salomon, J. A. (1998). Modeling the impact of global tuberculosis control strategies. Proc. Natl. Acad. Sci. USA 95, 13881-13886.
108. Ohara, N., Matsuoka, M., Nomaguchi, H., Naito, M., and Yamada, T. (2000). Inhibition of multiplication of Mycobacterium leprae in mouse foot pads by recombinant Bacillus Catmette-Guerin (BCG). Vaccine 18, 1294-1297.
109. Pablos-Mendez, A., Raviglione, M. C., Laszlo, A., Binkin, N., Rieder, H. L., Bustreo, F., Cohn, D. L., Lambregts-van Weezenbeek, C. S., Kim, S. J., Chaulet, P., and Nunn, P. (1998). Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N. Engl. J. Med. 338, 1641-1649.
110. Paglia, P., Medina, E., Arioli, I., Guzman, C. A., and Colombo, M. P. (1998). Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92, 3172-3176.
111. Pal, P. G., and Horwitz, M. A. (1992). Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60, 4781-4792.
112. Pan, Z. K., Ikonomidis, G., Lazenby, A., Pardoll, D., and Paterson, Y. (1995). A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nature Med. 1, 471-477.
113. Pang, T., Levine, M. M., Ivanoff, B., Wain, J., and Finlay, B. B. (1998). Typhoid fever-important issues still remain. Trends Microbiol. 6, 131-133.
114. Pasetti, M. F., Anderson, R. J., Noriega, F. R., Levine, M. M., and Sztein, M. B. (1999). Attenuated AguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. Clin. Immunol. 92, 76-89.
115. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K., Normark, S. J., and Harding, C. V. (1993). Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361, 359-362.
116. Philipp, W. J., Nair, S., Guglielmi, G., Lagranderie, M., Gicquel, B., and Cole, S. T. (1996). Physical mapping of Mycobacterium bovis BCG pasteur reveals differences from the genome map of Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology 142, 3135-3145.
117. Portnoy, D. A., and Jones, S. (1994). The cell biology of Listeria monocytogenes infection (escape from a vacuole). Ann. NY Acad. Sci. 730, 15-25.
118. Portnoy, D. A., Jacks, P. S., and Hinrichs, D. J. (1988). Role of hemolysin for the intracellular growth of Listeria monocytogenes. J. Exp. Med. 167, 1459-1471.
119. Ramshaw, I.A., and Ramsay, A. J. (2000). The prime-boost strategy: exciting prospects for improved vaccination. Immunol. Today 21, 163-165.
120. Roberts, A. D., Sonnenberg, M. G., Ordway, D. J., Furney, S. K., Brennan, P. J., Belisle, J. T., and Orme, I. M. (1995). Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunology 85, 502-508.
121. Roche, P. W., Triccas, J. A., and Winter, N. (1995). BCG vaccination against tuberculosis: past disappointments and future hopes. Trends. Microbiol. 3, 397-401.
122. Rodrigues, L. C., and Smith, P. G. (1990). Tuberculosis in developing countries and methods for its control. Trans. R. Soc. Trop. Med. Hyg. 84, 739-744.
123. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., and Amigorena, S. (1999). Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nature Cell Biol. 1, 362-368.
124. Salmond, G. P., and Reeves, P. J. (1993). Membrane traffic wardens and protein secretion in Gram-negative bacteria. Trends Biochem. Sci. 18, 7-12.
125. Salamon, H., Kato-Maeda, M., Small, P. M., Drenkow, J., and Gingeras, T. R. (2000). Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data. Genome Res. 10, 2044-2054.
126. Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M. D., Silverman, G. J., Lotz, M., Carson, D. A., and Raz, E. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
127. Schaible, U. E., Collins, H. L., and Kaufmann, S. H. (1999). Confrontation between intracellular bacteria and the immune system. Adv. Immunol. 71, 267-377.
128. Schirmbeck, R., Bohm, W., and Reimann, J. (1996). Virus-like particles induce MHC class I-restricted T cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology 39, 111-119.
129. + T cells using heterologous prime-boost immunisation strategies. Immunol. Rev. 170, 29-38.
130. Shen, H., Slifka, M. K., Matloubian, M., Jensen, E. R., Ahmed, R., and Miller, J. F. (1995). Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc. Natl. Acad. Sci. USA 92, 3987-3991.
131. Sizemore, D. R., Branstrom, A. A., and Sadoff, J. C. (1995). Attenuated Shigella as a DNA delivery vehicle for DMA-mediated immunization. Science 270, 299-302.
132. Skeiky, Y. A., Ovendale, P. J., Jen, S., Alderson, M. R., Dillon, D. C., Smith, S., Wilson, C. B., Orme, I. M., Reed, S. G., and Campos-Neto, A. (2000). T cell expression cloning of a Mycobacterium tuberculosis gene encoding a protective antigen associated with the early control of infection. J. Immunol. 165, 7140-7149.
133. Spreng, S., Dietrich, G., Niewiesk, S., ter Meulen, V., Gentschev, I., and Goebel, W. (2000). Novel bacterial systems for the delivery of recombinant protein or DNA. FEMS Immunol. Med. Microbiol. 27, 299-304.
134. Stenger, S., Hanson, D. A., Teitelbaum, R., Dewan, P., Niazi, K. R., Froelich, C. J., Ganz, T., Thoma-Uszynski, S., Melian, A., Bogdan, C. et al. (1998). An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121-125.
135. Stover, C. K., Bansal, G. P., Hanson, M. S., Burlein, J. E., Palaszynski, S. R., Young, J. F., Koenig, S., Young, D. B., Sadziene, A., and Barbour, A. G. (1993). Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med. 178, 197-209.
136. Street, N. E., and Mosmann, T. R. (1991). Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 5, 171-177.
137. Streit, J. A., Recker, T. J., Donelson, J. E., and Wilson, M. E. (2000). BCG expressing LCR1 of Leishmania chagasi induces protective immunity in susceptible mice. Exp. Parasitol. 94, 33-41.
138. Suhrbier, A. (1997). Multi-epitope DNA vaccines. Immunol. Cell Biol. 75, 402-408.
139. Sykes, K. F., and Johnston, S. A. (1999). Linear expression elements: a rapid, in vivo, method to screen for gene functions. Nature Biotechnol. 17, 355-359.
140. Tacket, C. O., and Levine, M. M. (1994). Typhoid vaccines - old and new. In: Molecular and Clinical Aspects of Vaccine Development, Ala' Aldeen and C. E. Hormaeche, eds. (Chichester, UK: John Wiley), pp. 156-178.
141. Talaat, A. M., Hunter, P., and Johnston, S. A. (2000). Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis. Nature Biotechnol. 18, 679-682.
142. Tanghe, A., Lefevre, P., Denis, O., D'Souza, S., Braibant, M., Lozes, E., Singh, M., Montgomery, D., Content, J., and Huygen, K. (1999). Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J. Immunol. 162, 1113-1119.
143. Tanghe, A., Denis, O., Lambrecht, B., Motte, V., van den Berg, T., and Huygen, K. (2000). Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect. Immun. 68, 3854-3860.
144. Tascon, R. E., Colston, M. J., Ragno, S., Stavropoulos, E., Gregory, D., and Lowrie, D. B. (1996). Vaccination against tuberculosis by DNA injection. Nature Med. 2, 888-892.
145. Thompson, R. J., Bouwer, H. G., Portnoy, D. A., and Frankel, F. R. (1998). Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth. Infect. Immun. 66, 3552-3561.
146. Tilney, L. G., and Portnoy, D. A. (1989). Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J. Cell Biol. 109, 1597-1608.
147. Torres, C. A., Iwasaki, A., Barber, B. H., and Robinson, H. L. (1997). Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immunol. 158, 4529-4532.
148. Triccas, J. A., Berthet, F. X., Pelicic, V., and Gicquel, B. (1999). Use of fluorescence induction and sucrose counterselection to identify Mycobacterium tuberculosis genes expressed within host cells. Microbiology 145, 2923-2930.
149. Triccas, J. A., and Gicquel, B. (2000). Life on the inside: probing Mycobacterium tuberculosis gene expression during infection. Immunol. Cell Biol. 78, 311-317.
150. Ulmer, J. B., Deck, R. R., Dewitt, C. M., Donnhly, J. I., and Liu, M. A. (1996). Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89, 59-67.
151. Underhill, D. M., Ozinsky, A., Hajjar, A. M., Stevens, A., Wilson, C. B., Bassetti, M., and Aderem, A. (1999). The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401, 811-815.
152. Verma, N. K., Ziegler, H. K., Wilson, M., Khan, M., Safley, S., Stocker, B. A., and Schoolnik, G. K. (1995). Delivery of class I and class II MHC-restricted T cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella. Vaccine 13, 142-150.
153. Wangoo, A., Brown, I. N., Marshall, B. G., Cook, H. T., Young, D. B., and Shaw, R. J. (2000). Bacille Calmette-Guerin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). Clin. Exp. Immunol. 119, 92-98.
154. Weiskirch, L. M., and Paterson, Y. (1997). Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease. Immunol. Rev. 158, 159-169.
155. Weiss, S. and Krusch, S. (2001). Bacteria-mediated transfer of eukaryotic expression plasmids to mammalian host cells. Biol. Chem. 382, 533-541.
156. Winter, N., Lagranderie, M., Rauzier, J., Timm, J., Leclerc, C., Guy, B., Kieny, M. P., Gheorghiu, M., and Gicquel, B. (1991). Expression of heterologous genes in Mycobacterium bovis BCG: induction of a cellular response against HIV-1 Nef protein. Gene 109, 47-54.
157. Winter, N., Lagranderie, M., Gangloff, S., Leclerc, C., Gheorghiu, M., and Gicquel, B. (1995). Recombinant BCG strains expressing the SIVmac251 nef gene induce proliferative and CTL responses against nef synthetic peptides in mice. Vaccine 13, 471-478.
158. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Feigner, P. L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
159. Yamada, H., Matsumoto, S., Matsumoto, T., Yamada, T., and Yamashita, U.
160. + T cells from subuniT vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis. Int. Immunol. 9, 1669-1676.
161. Zhu, Y. D., Fennelly, G., Miller, C., Tarara, R., Saxe, I., Bloom, B., and McChesney, M. (1997b). Recombinant bacille Calmette-Guerin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia. J. Infect. Dis. 176, 1445-1453.